---

National Blood Service

I have a letter from Andrew Pearce, who is the head of donor advocacy in the NHS. The second paragraph says:"““The review is at an early stage and is likely to take a few months. Although we cannot rule out that the review might eventually suggest that some of our supporting activities should be market-tested, this is by no means certain.””" There is some doubt in that letter, which is from someone within the blood system itself, about whether market-testing is going on with a view to something else happening. People do not test something for the market if they are not intending to put it out to tender.